Research on Critical Diseases of Infants Before and Just After Birth is Helping to Prevent and Cure Conditions That Have Eluded Medical Science for Many Years, Improving Outcomes for Our Precious Newborns
Kim Peterson and Michael Caplan, MD, review home-care instructions for Kim's newborns
When Kim Peterson's twins were born 11 weeks prematurely, she had never heard of neonatal necrotizing enterocolitis (NEC), a bowel-destroying disease that is the third leading cause of death of premature infants. But Michael Caplan, MD, Chairman of Pediatrics, her attending neonatologist, has won international acclaim for NIH-funded research on the causes and treatment of NEC. He diagnosed the disease as soon as Aaron showed the first symptoms. Immediate treatment prevented serious damage and the need for surgery on the extremely fragile newborn.
Superior clinical care for high-risk mothers and babies has attracted more than 30 investigators to peri-neonatal research at NorthShore University HealthSystem. NIH-funded researchers are studying the genetic role in pre-term labor and exploring new therapies for fetal growth retardation and preeclampsia. Other scientists are focusing on biochemical markers that appear to be highly damaging to the neonatal brain, and strategies to prevent and treat lung disease and fetal birth defects.
In 2006, Liz Ellrodt and her husband Scott Schweighauser established the Ellrodt-Schweighauser Family Chair in Perinatal Research.
Go to list of Principal Investigators in Peri-Neonatal research »